Phase 2 Alport Syndrome Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

BAY3401016; Biomarker Study Alport

Alport Syndrome

Bayer60 enrolled60 locationsNCT07211685

Recruiting

Phase 2

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Alport SyndromeFocal Segmental GlomerulosclerosisImmunoglobulin A Nephropathy+2 more

Travere Therapeutics, Inc.67 enrolled47 locationsNCT05003986